Lexicon Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 4,250,198 | 1.18% |
General Public | 61,120,346 | 16.9% |
Institutions | 121,022,367 | 33.5% |
VC/PE Firms | 175,099,384 | 48.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 47.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
175,099,384 | US$151.2m | 0% | 3.56% | |||
49,867,025 | US$43.1m | 28.9% | no data | |||
11,024,000 | US$9.5m | 88.6% | 0.12% | |||
10,133,014 | US$8.7m | 2.46% | no data | |||
8,091,098 | US$7.0m | 5.42% | no data | |||
5,451,204 | US$4.7m | 0% | 16.03% | |||
3,523,971 | US$3.0m | 8.41% | no data | |||
2,471,215 | US$2.1m | 6.82% | no data | |||
2,382,286 | US$2.1m | 0% | 0.08% | |||
2,327,110 | US$2.0m | 11.2% | no data | |||
2,304,150 | US$2.0m | 0% | 0.14% | |||
1,882,600 | US$1.6m | 229% | 0.01% | |||
1,730,821 | US$1.5m | 0.87% | 0.02% | |||
1,417,295 | US$1.2m | 4.28% | no data | |||
1,398,876 | US$1.2m | 134% | no data | |||
1,348,879 | US$1.2m | 0% | no data | |||
1,262,672 | US$1.1m | 0% | 0.06% | |||
1,230,050 | US$1.1m | -70.2% | no data | |||
1,211,924 | US$1.0m | 0% | 0.01% | |||
1,144,031 | US$987.7k | 14.7% | no data | |||
1,130,897 | US$976.4k | 368% | no data | |||
1,098,068 | US$948.1k | 0% | no data | |||
801,584 | US$692.1k | -90.3% | 0.03% | |||
732,747 | US$632.7k | -0.8% | no data | |||
731,138 | US$631.3k | 34.7% | 0.03% |